Nvidia's Chip Dominance and Robinhood's Investor Assault: How Markets Will React

Premarket trading saw significant moves in Nvidia, Robinhood, and Novartis. Nvidia surged 5% on strong chip demand; Robinhood rose 3% amid heavy user trading. Novartis fell 2% due to increased competition in the pharmaceutical sector. Will markets adjust to these shifts?

The New Phase of the Chip War

■Nvidia raised chip prices amid AI and data center demand.

■ASML reported a 10% capacity loss in semiconductor equipment.

■TSMC saw a 15% drop in orders from China.

Robinhood's Investor Onslaught

■Robinhood users account for 20% of sudden trades.

■AMC gained 8% from Robinhood's popularity.

■GameStop remains a key player in long-term investing.

Novartis Loses Ground in the Pharma Market

■Pfizer captured 3% of Novartis' market share.

■Moderna invested 12% in new drug development.

■Sanofi saw a 5% drop in drug sales.

The China-U.S. rare earth elements conflict could force Nvidia and ASML to face a 20% price hike by 2025. Meanwhile, Robinhood's growth and Novartis' market share will shape the future of the sector.